EMR · Emerson Electric Co · Insider Trading

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.90 to $161.98, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Includes 134 shares acquired under the Issuer's employee stock purchase plan since the Reporting Person's last Form 4 filing

Shares withheld for required minimum taxes upon vesting of previously reported stock grant under shareholder approved benefit plan exempt pursuant to Rule 16b-3.

Fair market value on date of withholding described in Note 1.

Includes 105 shares acquired under the Issuer's employee stock purchase plan since the Reporting Person's last Form 4 filing.

Grant to Reporting Person of 622 restricted stock units having a fair market value of $152.51 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d) in connection with annual retainer paid to all non-management directors.

Price is not applicable to acquisitions resulting from grants of restricted stock units.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.12 to $141.32, inclusive. The reporting person undertakes to provide Emerson Electric Co., any security holder of Emerson Electric Co., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Shares withheld for required minimum taxes upon vesting of previously reported stock grant under shareholder approved benefit plan exempt pursuant to Rule 16b-3.

Fair market value on date of withholding described in Note 1.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.32 to $142.33, inclusive. The reporting person undertakes to provide Emerson Electric Co., any security holder of Emerson Electric Co., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Bona fide gift by Reporting Person of 6,680 shares to a revocable trust of which the Reporting Person and the Reporting Person's spouse are co-trustees.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

Bona fide gift by Reporting Person of 6,680 shares to a revocable trust of which the Reporting Person and the Reporting Person's spouse are co-trustees.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.22 to $162.12, inclusive. The reporting person undertakes to provide Emerson Electric Co., any security holder of Emerson Electric Co., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.18 to $159.05, inclusive. The reporting person undertakes to provide Emerson Electric Co., any security holder of Emerson Electric Co., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Shares withheld for required minimum taxes upon vesting of previously reported stock grant under shareholder approved benefit plan exempt pursuant to Rule 16b-3.

Fair market value on date of withholding described in Note 1.

Bona fide gift by Reporting Person of 5,578 shares to a revocable trust of which the Reporting Person and the Reporting Person's spouse are co-trustees.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

Bona fide gift by Reporting Person of 5,578 shares to a revocable trust of which the Reporting Person and the Reporting Person's spouse are co-trustees.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.43 to $152.54, inclusive. The reporting person undertakes to provide Emerson Electric Co., any security holder of Emerson Electric Co., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).

Price is not applicable to acquisitions resulting from grants of restricted stock units.

Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).

Price is not applicable to acquisitions resulting from grants of restricted stock units.

Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).

Price is not applicable to acquisitions resulting from grants of restricted stock units.

Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).

Price is not applicable to acquisitions resulting from grants of restricted stock units.

Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).

Price is not applicable to acquisitions resulting from grants of restricted stock units.

Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).

Price is not applicable to acquisitions resulting from grants of restricted stock units.

Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).

Price is not applicable to acquisitions resulting from grants of restricted stock units.

Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).

Price is not applicable to acquisitions resulting from grants of restricted stock units.

Grant to Reporting Person of 1,251 restricted stock units having a fair market value of $151.795 per unit on the date of grant under shareholder approved benefits plan pursuant to Rule 16b-3(d).

Price is not applicable to acquisitions resulting from grants of restricted stock units.

Includes 229 shares acquired under a dividend reinvestment plan since the Reporting Person's last Form 4 filing.

Shares withheld for required minimum taxes upon vesting of previously reported stock grant under shareholder approved benefit plan exempt pursuant to Rule 16b-3.

Fair market value on date of withholding described in Note 1.

Shares withheld for required minimum taxes upon vesting of previously reported restricted stock unit grant under shareholder approved benefit plan exempt pursuant to Rule 16b-3.

Fair market value on date of withholding described in Note 3.

Shares withheld for required minimum taxes upon vesting of previously reported restricted stock grant under shareholder approved benefit plan exempt pursuant to Rule 16b-3.

Fair market value on date of withholding described in Note 1.

Bona fide gift by Reporting Person of 3,120 shares to a revocable trust of which the Reporting Person and the Reporting Person's Spouse are co-trustees.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

Bona fide gift by Reporting Person of 3,120 shares to a revocable trust of which the Reporting Person and the Reporting Person's Spouse are co-trustees.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

Bona Fide gift by Reporting Person of 39,492 shares to a revocable trust of which the Reporting Person and the Reporting Person's spouse are co-trustees.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

Bona Fide gift by Reporting Person of 39,492 shares to a revocable trust of which the Reporting Person and the Reporting Person's spouse are co-trustees.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

Bona Fide gift by Reporting Person of 4,000 shares.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

Bona Fide gift by Reporting Person of 2,267 shares.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

Shares withheld for taxes exempt under Rule 16-b3 resulting from non-qualified stock option exercise.

Exercise of 4,773 incentive stock options and 10,227 non-qualified stock options exempt under Rule 16b-3.

Price is not applicable to stock options received as incentive compensation.

The options vested in three equal annual installments beginning on the date indicated.

Exercise of 4,773 incentive stock options and 10,227 non-qualified stock options exempt under Rule 16b-3.

Exercise of 4,773 incentive stock options and 10,227 non-qualified stock options exempt under Rule 16b-3.

Price is not applicable to stock options received as incentive compensation.

The options vested in three equal annual installments beginning on the date indicated.

Exercise of 4,773 incentive stock options and 10,227 non-qualified stock options exempt under Rule 16b-3.

Payment of option exercise price by delivering securities.

Bona fide gift by Reporting Person of 115,705 shares to a revocable trust of which the Reporting Person and the Reporting Person's spouse are co-trustees.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

Bona fide gift by Reporting Person of 115,705 shares to a revocable trust of which the Reporting Person and the Reporting Person's spouse are co-trustees.

Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.

The exercise price is equal to 200% of the closing price of Issuer's common stock on the date of grant.

Grant of stock options under shareholder approved benefit plan exempt pursuant to Rule 16b-3(d).

Price is not applicable to stock options received as incentive compensation.

The Reporting person was awarded a total of 350,000 stock options on 11/13/2025 in 5 tranches of 70,000 stock options each, with each tranche having a different exercise price. Each of the 5 tranches of 70,000 stock options become exercisable in five equal annual installments of 14,000 each beginning on 11/13/2026.

The exercise price is equal to 175% of the closing price of Issuer's common stock on the date of grant.

Grant of stock options under shareholder approved benefit plan exempt pursuant to Rule 16b-3(d).

Price is not applicable to stock options received as incentive compensation.

The Reporting person was awarded a total of 350,000 stock options on 11/13/2025 in 5 tranches of 70,000 stock options each, with each tranche having a different exercise price. Each of the 5 tranches of 70,000 stock options become exercisable in five equal annual installments of 14,000 each beginning on 11/13/2026.

The exercise price is equal to 175% of the closing price of Issuer's common stock on the date of grant.

Grant of stock options under shareholder approved benefit plan exempt pursuant to Rule 16b-3(d).

Price is not applicable to stock options received as incentive compensation.

The Reporting person was awarded a total of 350,000 stock options on 11/13/2025 in 5 tranches of 70,000 stock options each, with each tranche having a different exercise price. Each of the 5 tranches of 70,000 stock options become exercisable in five equal annual installments of 14,000 each beginning on 11/13/2026.

The exercise price is equal to 200% of the closing price of Issuer's common stock on the date of grant.

Grant of stock options under shareholder approved benefit plan exempt pursuant to Rule 16b-3(d).

Price is not applicable to stock options received as incentive compensation.

The Reporting person was awarded a total of 350,000 stock options on 11/13/2025 in 5 tranches of 70,000 stock options each, with each tranche having a different exercise price. Each of the 5 tranches of 70,000 stock options become exercisable in five equal annual installments of 14,000 each beginning on 11/13/2026.

Grant of stock options under shareholder approved benefit plan exempt pursuant to Rule 16b-3(d).

Price is not applicable to stock options received as incentive compensation.

The Reporting person was awarded a total of 350,000 stock options on 11/13/2025 in 5 tranches of 70,000 stock options each, with each tranche having a different exercise price. Each of the 5 tranches of 70,000 stock options become exercisable in five equal annual installments of 14,000 each beginning on 11/13/2026.

The exercise price is equal to 150% of the closing price of Issuer's common stock on the date of grant.

Grant of stock options under shareholder approved benefit plan exempt pursuant to Rule 16b-3(d).

Price is not applicable to stock options received as incentive compensation.

The Reporting person was awarded a total of 350,000 stock options on 11/13/2025 in 5 tranches of 70,000 stock options each, with each tranche having a different exercise price. Each of the 5 tranches of 70,000 stock options become exercisable in five equal annual installments of 14,000 each beginning on 11/13/2026.

The exercise price is equal to 125% of the closing price of Issuer's common stock on the date of grant.

Grant of stock options under shareholder approved benefit plan exempt pursuant to Rule 16b-3(d).

Price is not applicable to stock options received as incentive compensation.

The Reporting person was awarded a total of 350,000 stock options on 11/13/2025 in 5 tranches of 70,000 stock options each, with each tranche having a different exercise price. Each of the 5 tranches of 70,000 stock options become exercisable in five equal annual installments of 14,000 each beginning on 11/13/2026.